In an acute colitis mouse model, a prophylactic MFGM treatment followed by DSS increased the gene expression of Muc2 and Muc4, which was associated with the enrichment of nine genera, including Bifidobacterium [60]. The gene discussed is MUC2; the disease is colitis.